BIO.News Newsletter

Congratulations to the several BIO members who were included in Endpoints News’ 20 Under 40 in Biopharma! We’re proud to be working with so many next-generation biotech leaders.  Today, we take a closer look at how animal biotech policy can help us fight coronavirus, as well as answer some of your questions about antibodies, in about 860 words, just over 4 minutes.

It’s World Health Day, a public health awareness day promoted by the World Health Organization (WHO)—and this year’s theme celebrates nurses and midwives, many of whom are caring for patients on the frontlines of the COVID-19 pandemic. We’re thinking of you today, and every day, as we race to find therapeutics and vaccines and deliver diagnostics and other tools and supplies for you to do your jobs safely. Today, we’re looking at one example of how international collaboration is doing just…

It’s a new week. Today, we’re taking a look at how several BIO members are collaborating on COVID-19—from developing innovative science to sending their employees to the front lines of the fight. Here are about 720 words, or 3 minutes, 30 seconds.

It’s the weekend, and we hope you are finding a little rest, relaxation, and joy at home.  In today’s Special Weekend Edition of Good Day BIO, we’re taking a brief break from all the news surrounding COVID-19 to share the latest episode of the I AM BIO podcast: Sickle Cell Saviors. Sickle cell disease is an inherited red blood cell disease that can cause debilitating pain and lifelong complications. In the United States, the disease disproportionately affects African Americans.  In November,…

It's Friday, and we've got a big announcement today. Here's a quick 575 words (3 minutes) with news on the 2020 BIO International Convention, as well as some more links to industry news. 

Today, we let our international affairs team take over Good Day BIO, to share a little bit about some of BIO’s important international work on COVID-19 and how BIO members are working with companies around the world on vaccines and treatments. (Read through to the end to get to more news from the United States, too.) Here are 830 words, or 4 minutes, 10 seconds.

It's a new month. Today, we're taking a look at recent misguided decisions by the EPA, as well as a must-listen radio interview with BIO CEO Jim Greenwood on what the industry's doing about coronavirus and why the drug pricing debate still matters. Here are 800 words, about 4 minutes.

We missed National Doctors Day yesterday, so we want to give a special shoutout to the doctors, nurses, and other medical professionals on the frontlines of the COVID-19 battle, putting themselves and their families in danger to save patients’ lives. We’re working hard to bring you the diagnostics, treatments, vaccines, and supplies you and your patients need, as quickly as possible. Today, we’re taking a quick look at the impact of COVID-19 on clinical trials, as well as an example of…

It’s another Monday in lockdown—but we have promising developments from a few member companies. First, we have a new episode of the I AM BIO Podcast, with insight on when we’ll have a COVID-19 vaccine. Second, another company is using synthetic biology to manufacture sustainable, moisturizing hand sanitizer—which you can actually order now—as well as a vaccine ingredient. Here are just under 900 words, or about 4-and-a-half minutes, to start your week.

It’s Friday. As we close a busy week, and prepare for another one ahead, here’s a 680-word read (3 and a half minutes) on our new survey with BioCentury on how COVID-19 is affecting clinical trials—and some thoughts on the industry’s incredible work to collaborate.